Exzeo Group (XZO) stock drops 6% to start 2026 as traders reset positions
4 January 2026
2 mins read

Exzeo Group (XZO) stock drops 6% to start 2026 as traders reset positions

NEW YORK, Jan 3, 2026, 8:54 PM ET — Market closed

  • Exzeo ended Friday down 6.14% at $22.76, after touching $24.49 earlier in the session. 1
  • The slide followed a late-December run that pushed the stock to a $24.60 high on Dec. 31. 1
  • Investors head into the first full week of 2026 focused on U.S. jobs data on Jan. 9 and inflation data on Jan. 13. 2

Exzeo Group, Inc. shares closed down 6.14% on Friday at $22.76, a sharp pullback on the first trading day of 2026 for the newly listed insurance-technology company. 1

Moves in fresh IPOs can be amplified when the public float — the shares available for trading — is relatively small. Exzeo’s parent, HCI Group, retained an 81.5% ownership stake after the offering, according to Reuters. 3

The drop came as Wall Street ended mixed and Treasury yields ticked higher, a combination that can cool appetite for growth-oriented stocks. The S&P 500 rose 0.19% on Friday while the Nasdaq slipped 0.03%, and the 10-year Treasury yield rose to about 4.19%. 4

“The market is looking for direction,” Matthew Maley, chief market strategist at Miller Tabak, said in a Reuters report on what investors are watching as 2026 begins. 2

Exzeo opened at $24.49 on Friday and never traded above that level, before sliding to an intraday low of $22.19 and closing at $22.76. Volume was 423,789 shares, according to StockAnalysis data. 1

The decline snapped a three-session climb into year-end. Exzeo rose on Dec. 29, Dec. 30 and Dec. 31 and hit a $24.60 high on the last trading day of 2025 before reversing on Friday. 1

The company’s most recent operating update came with its third-quarter results on Dec. 10, when it reported revenue up 90% year over year to $55.2 million and “managed premium” — the gross dollar value of premiums processed or administered on its platform — up 142.1% to $1.2 billion. 5

Exzeo describes itself as an “Insurance-as-a-Service” provider to property-and-casualty insurers, focused on the homeowners market. The company said a fifth insurance company joined its platform in the third quarter, with a sixth joining in the fourth quarter. 5

At Friday’s close, Exzeo’s market value was about $2.07 billion and the stock traded at roughly 26 times trailing earnings, according to StockAnalysis. The site shows a “Buy” consensus from two analysts and a $27 price target. 6

Other insurance-technology and adjacent names were volatile in the same session. Lemonade rose about 6.7%, while Guidewire fell about 6.7% and HCI Group slid about 4.0%, according to market data.

Before markets reopen on Monday, investors will be watching whether incoming economic data forces a rethink on interest-rate cuts, a key driver for equity valuations. Reuters flagged the U.S. jobs report due Jan. 9 and a consumer price index report due Jan. 13 as early market-moving events. 2

January also brings the start of fourth-quarter earnings season, with JPMorgan set to report on Jan. 13, Reuters reported. With valuations elevated, investors are leaning on expectations for another year of profit growth to justify prices. 2

For Exzeo specifically, earnings-date trackers such as Zacks list March 11 as an estimated next report date. Investors are likely to look for updates on carrier additions, managed premium growth and profitability after the company’s strong third-quarter results. 7

Technically, traders are watching whether the stock can hold above the $22 area after Friday’s $22.19 low, and whether it can retest the $24.60 peak set on Dec. 31. 1

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
Wave Life Sciences stock drops 6% as WVE traders size up next obesity data
Previous Story

Wave Life Sciences stock drops 6% as WVE traders size up next obesity data

Diebold Nixdorf stock sinks nearly 6% to start 2026 as traders brace for jobs data
Next Story

Diebold Nixdorf stock sinks nearly 6% to start 2026 as traders brace for jobs data

Go toTop